TARA vs. OKUR

Last updated Apr 1, 2026

Compare and contrast key facts about Protara Therapeutics, Inc. (TARA) and OnKure Therapeutics, Inc (OKUR).

Performance

TARA vs. OKUR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Protara Therapeutics, Inc. (TARA) and OnKure Therapeutics, Inc (OKUR). The values are adjusted to include any dividend payments, if applicable.

TARA vs. OKUR - Yearly Performance Comparison

	2026 (YTD)	2025	2024
TARA Protara Therapeutics, Inc.	-2.25%	0.95%	200.00%
OKUR OnKure Therapeutics, Inc	42.76%	-66.28%	-53.89%

Fundamentals

Market Cap TARA : $239.87M OKUR : $55.96M
EPS TARA : -$1.32 OKUR : $0.00
PB Ratio TARA : 1.22 OKUR : 1.00
Total Revenue (TTM) TARA : $0.00 OKUR : $0.00
Gross Profit (TTM) TARA : -$88.00K OKUR : $0.00
EBITDA (TTM) TARA : -$61.28M OKUR : -$62.95M

Returns By Period

In the year-to-date period, TARA achieves a -2.25% return, which is significantly lower than OKUR's 42.76% return.

TARA

• 1D: 7.42%
• 1M: -18.08%
• YTD: -2.25%
• 6M: 19.77%
• 1Y: 22.30%
• 3Y*: 18.51%
• 5Y*: -19.66%
• 10Y*: -33.87%

OKUR

• 1D: 9.23%
• 1M: 52.77%
• YTD: 42.76%
• 6M: 50.55%
• 1Y: -3.72%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

TARA vs. OKUR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TARA

TARA Risk / Return Rank: 52
TARA Sharpe Ratio Rank: 51
TARA Sortino Ratio Rank: 56
TARA Omega Ratio Rank: 54
TARA Calmar Ratio Rank: 51
TARA Martin Ratio Rank: 48

OKUR

OKUR Risk / Return Rank: 39
OKUR Sharpe Ratio Rank: 38
OKUR Sortino Ratio Rank: 42
OKUR Omega Ratio Rank: 40
OKUR Calmar Ratio Rank: 37
OKUR Martin Ratio Rank: 38

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TARA vs. OKUR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Protara Therapeutics, Inc. (TARA) and OnKure Therapeutics, Inc (OKUR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TARA	OKUR	Difference
Sharpe ratio Return per unit of total volatility	0.27	-0.05	+0.32
Sortino ratio Return per unit of downside risk	1.01	0.52	+0.49
Omega ratio Gain probability vs. loss probability	1.13	1.06	+0.07
Calmar ratio Return relative to maximum drawdown	0.38	-0.12	+0.51
Martin ratio Return relative to average drawdown	0.61	-0.20	+0.81
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TARA vs. OKUR - Sharpe Ratio Comparison

The current TARA Sharpe Ratio is 0.27, which is higher than the OKUR Sharpe Ratio of -0.05. The chart below compares the historical Sharpe Ratios of TARA and OKUR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	TARA	OKUR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.27	-0.05	+0.32
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.24	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.37	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.36	-0.87	+0.51

Correlation

The correlation between TARA and OKUR is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

TARA vs. OKUR - Dividend Comparison

Neither TARA nor OKUR has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

TARA vs. OKUR - Drawdown Comparison

The maximum TARA drawdown since its inception was -99.86%, which is greater than OKUR's maximum drawdown of -90.47%. Use the drawdown chart below to compare losses from any high point for TARA and OKUR.

Drawdown Indicators

	TARA	OKUR	Difference
Max Drawdown Largest peak-to-trough decline	-99.86%	-90.47%	-9.39%
Max Drawdown (1Y) Largest decline over 1 year	-35.85%	-57.04%	+21.19%
Max Drawdown (5Y) Largest decline over 5 years	-93.38%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-99.75%	—	—
Current Drawdown Current decline from peak	-99.35%	-78.45%	-20.90%
Average Drawdown Average peak-to-trough decline	-84.87%	-72.99%	-11.88%
Ulcer Index Depth and duration of drawdowns from previous peaks	22.51%	36.72%	-14.21%

Volatility

TARA vs. OKUR - Volatility Comparison

The current volatility for Protara Therapeutics, Inc. (TARA) is 15.63%, while OnKure Therapeutics, Inc (OKUR) has a volatility of 29.54%. This indicates that TARA experiences smaller price fluctuations and is considered to be less risky than OKUR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TARA	OKUR	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.63%	29.54%	-13.91%
Volatility (6M) Calculated over the trailing 6-month period	67.48%	56.20%	+11.28%
Volatility (1Y) Calculated over the trailing 1-year period	83.61%	76.83%	+6.78%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	81.37%	73.77%	+7.60%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	91.31%	73.77%	+17.54%

Financials